A head-to-head comparison review of biological and toxicological studies of isomaltulose, d-tagatose, and trehalose on glycemic control

Crit Rev Food Sci Nutr. 2022;62(21):5679-5704. doi: 10.1080/10408398.2021.1895057. Epub 2021 Mar 10.

Abstract

Diabetes mellitus is the most common metabolic disorder contributing to significant morbidity and mortality in humans. Different preventive and therapeutic agents, as well as various pharmacological strategies or non-pharmacological tools, improve the glycemic profile of diabetic patients. Isomaltulose, d-tagatose, and trehalose are naturally occurring, low glycemic sugars that are not synthesized by humans but widely used in food industries. Various studies have shown that these carbohydrates can regulate glucose metabolism and provide support in maintaining glucose homeostasis in patients with diabetes, but also can improve insulin response, subsequently leading to better control of hyperglycemia. In this review, we discussed the anti-hyperglycemic effects of isomaltulose, D-tagatose, and trehalose, comparing their properties with other known sweeteners, and highlighting their importance for the development of the pharmaceutical and food industries.

Keywords: D-tagatose; Isomaltulose; diabetes; insulin resistance; nutraceuticals; obesity; trehalose.

Publication types

  • Review

MeSH terms

  • Blood Glucose / metabolism
  • Diabetes Mellitus* / drug therapy
  • Glycemic Control
  • Hexoses
  • Humans
  • Isomaltose / analogs & derivatives
  • Isomaltose / therapeutic use
  • Trehalose* / pharmacology

Substances

  • Blood Glucose
  • Hexoses
  • Isomaltose
  • Trehalose
  • tagatose
  • isomaltulose